AU2621888A - Omeprazole for treatment of diseases related to bone loss - Google Patents

Omeprazole for treatment of diseases related to bone loss

Info

Publication number
AU2621888A
AU2621888A AU26218/88A AU2621888A AU2621888A AU 2621888 A AU2621888 A AU 2621888A AU 26218/88 A AU26218/88 A AU 26218/88A AU 2621888 A AU2621888 A AU 2621888A AU 2621888 A AU2621888 A AU 2621888A
Authority
AU
Australia
Prior art keywords
omeprazole
treatment
bone loss
diseases related
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26218/88A
Other languages
English (en)
Inventor
Rolf Hakanson
Per Linderg
Kalervo Vaananen
Bjorn Wallmark
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE8704247A external-priority patent/SE8704247D0/xx
Priority claimed from SE8704436A external-priority patent/SE8704436D0/xx
Application filed by Hassle AB filed Critical Hassle AB
Publication of AU2621888A publication Critical patent/AU2621888A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU26218/88A 1987-10-30 1988-10-27 Omeprazole for treatment of diseases related to bone loss Abandoned AU2621888A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE8704247 1987-10-30
SE8704247A SE8704247D0 (sv) 1987-10-30 1987-10-30 Method of treatment
SE8704436 1987-11-13
SE8704436A SE8704436D0 (sv) 1987-11-13 1987-11-13 Anvendning av antisekretoriska substanser for nya indikationer

Publications (1)

Publication Number Publication Date
AU2621888A true AU2621888A (en) 1989-05-23

Family

ID=26660006

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26218/88A Abandoned AU2621888A (en) 1987-10-30 1988-10-27 Omeprazole for treatment of diseases related to bone loss

Country Status (9)

Country Link
EP (1) EP0338066A1 (de)
JP (1) JPH02501930A (de)
KR (1) KR890701580A (de)
AU (1) AU2621888A (de)
DK (1) DK322289A (de)
HU (1) HU886738D0 (de)
IL (2) IL88207A (de)
MY (1) MY103790A (de)
WO (2) WO1989003830A1 (de)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU626641B2 (en) * 1989-02-09 1992-08-06 Aktiebolaget Hassle Use of omeprazole as an antimicrobial agent
AU636866B2 (en) * 1988-12-22 1993-05-13 Aktiebolaget Hassle Therapeutically active substituted benzimidazole and process for its preparation
AU649456B2 (en) * 1990-06-20 1994-05-26 Astra Aktiebolag Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
AU649453B2 (en) * 1990-06-20 1994-05-26 Astra Aktiebolag Substituted benzimidazoles, process for their preparation and their pharmaceutical use

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5081253A (en) * 1989-12-21 1992-01-14 American Home Products Corporation Imidazo(4,5-c)pyridines as antiosteoporotic agents
JP2000514048A (ja) * 1996-06-20 2000-10-24 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム 薬理学的活性調製物を提供するための化合物および方法ならびにそれらの使用
US6316020B1 (en) * 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
DE10040052A1 (de) * 2000-08-11 2002-03-07 Univ Eberhard Karls Verwendung von Protonenpumpen-Hemmern zur Behandlung von Entzündungen, insbesondere von Erkrankungen des Bewegungsapparates
KR100453916B1 (ko) * 2002-03-11 2004-10-20 주식회사 코오롱 1,2,5,6-테트라히드로피리디닐벤즈이미다졸 유도체 및 그제조방법
GB0403165D0 (en) * 2004-02-12 2004-03-17 Ct Novel uses for proton pump inhibitors
KR100638649B1 (ko) 2006-06-27 2006-10-31 신한전기공업주식회사 절연보강된 코일을 구비한 건식 변압기
EP2749285B1 (de) * 2011-08-26 2016-11-02 National University Corporation Nagoya University Osteogenese-promotor und seine verwendung

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE416649B (sv) * 1974-05-16 1981-01-26 Haessle Ab Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
SE8500996D0 (sv) * 1985-03-01 1985-03-01 Haessle Ab Method of treatment

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU636866B2 (en) * 1988-12-22 1993-05-13 Aktiebolaget Hassle Therapeutically active substituted benzimidazole and process for its preparation
AU626641B2 (en) * 1989-02-09 1992-08-06 Aktiebolaget Hassle Use of omeprazole as an antimicrobial agent
AU649456B2 (en) * 1990-06-20 1994-05-26 Astra Aktiebolag Dialkoxy-pyridinyl-benzimidazole derivatives, process for their preparation and their pharmaceutical use
AU649453B2 (en) * 1990-06-20 1994-05-26 Astra Aktiebolag Substituted benzimidazoles, process for their preparation and their pharmaceutical use

Also Published As

Publication number Publication date
WO1989003829A1 (en) 1989-05-05
WO1989003830A1 (en) 1989-05-05
JPH02501930A (ja) 1990-06-28
KR890701580A (ko) 1989-12-21
DK322289D0 (da) 1989-06-28
EP0338066A1 (de) 1989-10-25
IL88207A (en) 1993-03-15
DK322289A (da) 1989-06-28
MY103790A (en) 1993-09-30
IL88207A0 (en) 1989-06-30
HU886738D0 (en) 1990-02-28
IL88206A0 (en) 1989-06-30

Similar Documents

Publication Publication Date Title
AU573160B2 (en) Treatment of tissue degenerative inflammatory disease
AU1811788A (en) Promotion of healing of meniscal tissue
HUT47022A (en) Process for production of medical compositions
AU6898287A (en) Treatment of bone loss
AU1193288A (en) Composition for treatment of acne
GB8706141D0 (en) Treatment of damaged limb
ZA885370B (en) Dna clone of human tissue factor inhibitor
AU6974687A (en) Treatment of immune diseases using diphenylhydantoin
ZA898605B (en) Compositions for topical treatment of skin diseases
AU2621888A (en) Omeprazole for treatment of diseases related to bone loss
AU2690684A (en) Methods and pharmaceutical compositions for the treatment of hyperplastic diseases of the skin
ZA883744B (en) Promotion of healing of meniscal tissue
HU886797D0 (en) Process for production of medical compositions against caries of bones
AU613355B2 (en) Method for treating skin diseases
AU1811388A (en) Method of treatment for retroviral infectious diseases
HUT47591A (en) Process for production of nucleozides with healing effect and medical compositions containing them
GB8812533D0 (en) Instrument for surgical treatment of pieces of tissue
AU1541088A (en) Composition for the treatment of the epiderm
AU2251288A (en) Sequential improved method for treatment of human blood- clotting factor products
AU2207188A (en) Device for treatment of gum disease
AU1306388A (en) Preparation for treatment of skin disorders
GB8715914D0 (en) Treatment of cerabral disorders
NO173145C (no) Fremgangsmaate for behandling av voerter
GB8722529D0 (en) Treatment of burns
AU2473388A (en) Treatment of factor viii inhibitors